醌NADH脫氫酶1(NQO1)單克隆抗體
Monoclonal Antibody to NADH Dehydrogenase, Quinone 1 (NQO1)
DHQU; DIA4; DTD; NMOR1; NMORI; QR1; Azoreductase; DT-diaphorase; Menadione reductase; Phylloquinone reductase; Quinone reductase 1; NAD(P)H:quinone oxidoreductase 1
- 編號UMAL969Hu24
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)C5
- Ig亞型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 -
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度1mg/mL
- 且適物種Rattus norvegicus (Rat，大鼠)
- 應(yīng)用WB,IHC
如果抗體需用于流式細(xì)胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 暫無報價 暫無報價 暫無報價 暫無報價 暫無報價
- 欲了解實(shí)際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P;
Sample: Rat Colon Tissue
Primary Ab: 30μg/ml Mouse Anti-Human NQO1 Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
Western Blot; Samples: Lane1: A549 cell lysate; Lane2: HepG2 cell lysate; Lane3: K562 cell lysate; Lane4: LO2 cell lysate;
Primary Ab: 0.2μg/ml Mouse Anti-Human NQO1 Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對NQO1的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識別NQO1。
用法
Western blotting: 0.1-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長臂生物素標(biāo)記試劑盒
實(shí)時熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPL969Hu01 | 醌NADH脫氫酶1(NQO1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPL969Hu01 | 醌NADH脫氫酶1(NQO1)活性蛋白 | Cell?culture;?Activity?Assays. |
| UPAL969Hu01 | 醌NADH脫氫酶1(NQO1)多克隆抗體 | WB; IHC; ICC/IF; FCM |
| UMAL969Hu22 | 醌NADH脫氫酶1(NQO1)單克隆抗體 | WB |
| UMAL969Hu24 | 醌NADH脫氫酶1(NQO1)單克隆抗體 | WB,IHC |
| UMAL969Hu21 | 醌NADH脫氫酶1(NQO1)單克隆抗體 | WB; IHC; ICC; IP. |
| USEL969Hu | 醌NADH脫氫酶1(NQO1)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULML969Hu | 醌NADH脫氫酶1(NQO1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Hypertension | Transcription factor Nrf2 protects renal dopamine D1 receptor function during oxidative stress. [Pubmed: 23876469] |
| Free Radical Research | Notoginsenoside R1-mediated neuroprotection involves estrogen receptor-dependent crosstalk between Akt and ERK1/2 pathways: A novel mechanism of Nrf2/ARE signaling activation [Informahealthcare: Source] |
| physiological reports | Antioxidant resveratrol restores renal sodium transport regulation in SHR [PubMed: 26603454] |
| Biol Chem | Genetic association of NAD (P) H Quinone Oxidoreductase (NQO1* 2) polymorphism with NQO1 levels and risk of diabetic nephropathy [Pubmed:27078674] |
| Experimental Parasitology | Sodium arsenite augments sensitivity of Echinococcus granulosus protoscoleces to albendazole [Pubmed: 30790573] |
| International Journal of Nanomedicine | Gold Nanoparticles Perturb Drug-Metabolizing Enzymes and Antioxidants in the Livers of Male Rats: Potential Impact on Drug Interactions [Pubmed: 32764932] |
| Exp Parasitol | In vitro protoscolicidal effects of lithocholic acid on protoscoleces of Echinococcus granulosus and its mechanism [Pubmed:35594934] |
